The essentials
Medicare Part D subsidies expire after 2026, projected to increase premiums 6% for 25 million beneficiaries.
The Trump administration is ending the Medicare Part D premium subsidy program after 2026, affecting nearly 25 million people enrolled in standalone drug plans. The Biden administration's subsidy had reduced premiums by 27-40 percent, providing substantial relief to beneficiaries. Following the subsidy termination, Medicare Part D premiums are projected to increase 6 percent in 2027, representing a significant shift in out-of-pocket costs for seniors.
The expiration marks a substantial policy change for prescription drug coverage under Medicare. Beneficiaries currently relying on reduced premiums will face higher costs as the program winds down, with the full impact materializing after 2026.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Subsidy expiration shifts costs to millions of seniors
Nearly 25 million beneficiaries currently receive 27-40 percent premium reductions that will disappear after 2026. The projected 6 percent increase in 2027 represents direct impact on household budgets for seniors managing chronic conditions requiring ongoing prescription coverage.
Policy shift takes full effect in 2027 following 2026 deadline
The subsidy program operates through 2026, with the policy change taking effect in 2027 when premiums are projected to increase 6 percent. The transition period allows beneficiaries and the healthcare system time to adjust to the new premium structure for standalone drug plans.